American Healthcare REIT (NYSE: AHR) insider transactions
In the twelve months to 10 November 2026, executives and directors of American Healthcare REIT reported 10 open-market sales of 93,778 shares ($4.6m) and 0 open-market purchases, by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 10 November 2026 | Estes Scott A | Director | Open-market sale | −2,500 | $59.32 | 18,989 | Form 4 |
| 25 September 2026 | Foster Mark E. | EVP, GC & Secretary | Open-market sale | −1,500 | $52.06 | 50,117 | Form 4 |
| 1 September 2026 | Foster Mark E. | EVP, GC & Secretary | Open-market sale | −2,000 | $55.39 | 51,617 | Form 4 |
| 21 July 2026 | Prosky Danny | Director | Shares withheld for tax | −59,945 | $56.66 | 286,524 | Form 4 |
| 21 July 2026 | Prosky Danny | Director | Option exercise | +30,886 | — | 317,410 | Form 4 |
| 21 July 2026 | Prosky Danny | Director | Shares withheld for tax | −16,663 | $56.66 | 300,747 | Form 4 |
| 21 July 2026 | Prosky Danny | Director | Option exercise | +20,912 | — | 321,659 | Form 4 |
| 21 July 2026 | Prosky Danny | Director | Shares withheld for tax | −11,283 | $56.66 | 310,376 | Form 4 |
| 21 July 2026 | Prosky Danny | Director | Grant or award | +2,594 | — | 312,970 | Form 4 |
| 26 June 2026 | Peay Brian | Chief Financial Officer | Open-market sale | −25,000 | $50.70 | 152,700 | Form 4 |
| 24 June 2026 | Estes Scott A | Director | Grant or award | +2,594 | — | 21,489 | Form 4 |
| 24 June 2026 | Hurley Dianne | Director | Grant or award | +2,594 | — | 34,037 | Form 4 |
| 24 June 2026 | Flornes Brian J. | Director | Grant or award | +2,594 | — | 33,020 | Form 4 |
| 24 June 2026 | Streiff Mathieu B. | Director | Grant or award | +2,594 | — | 34,971 | Form 4 |
| 24 June 2026 | Smith Wilbur H III | Director | Grant or award | +2,594 | — | 35,013 | Form 4 |
| 24 June 2026 | O'Quinn Marvin R | Director | Grant or award | +2,594 | — | 20,656 | Form 4 |
| 24 June 2026 | Richardson Valerie | Director | Grant or award | +2,594 | — | 20,656 | Form 4 |
| 24 June 2026 | Foster Mark E. | EVP, GC & Secretary | Open-market sale | −2,500 | $48.58 | 52,995 | Form 4 |
| 1 June 2026 | Foster Mark E. | EVP, GC & Secretary | Open-market sale | −2,000 | $48.32 | 55,495 | Form 4 |
| 6 April 2026 | Prosky Danny | Director | Option exercise | +15,924 | — | 355,065 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the American Healthcare REIT page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.